These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37213552)

  • 1. A dataset of multi-contrast unbiased average MRI templates of a Parkinson's disease population.
    Madge V; Fonov VS; Xiao Y; Zou L; Jackson C; Postuma RB; Dagher A; Fon EA; Collins DL
    Data Brief; 2023 Jun; 48():109141. PubMed ID: 37213552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-contrast unbiased MRI atlas of a Parkinson's disease population.
    Xiao Y; Fonov V; Bériault S; Al Subaie F; Chakravarty MM; Sadikot AF; Pike GB; Collins DL
    Int J Comput Assist Radiol Surg; 2015 Mar; 10(3):329-41. PubMed ID: 24841147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dataset of multi-contrast population-averaged brain MRI atlases of a Parkinson׳s disease cohort.
    Xiao Y; Fonov V; Chakravarty MM; Beriault S; Al Subaie F; Sadikot A; Pike GB; Bertrand G; Collins DL
    Data Brief; 2017 Jun; 12():370-379. PubMed ID: 28491942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients.
    Reimão S; Pita Lobo P; Neutel D; Correia Guedes L; Coelho M; Rosa MM; Ferreira J; Abreu D; Gonçalves N; Morgado C; Nunes RG; Campos J; Ferreira JJ
    Eur J Neurol; 2015 Mar; 22(3):540-6. PubMed ID: 25534480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patch-based label fusion segmentation of brainstem structures with dual-contrast MRI for Parkinson's disease.
    Xiao Y; Fonov VS; Beriault S; Gerard I; Sadikot AF; Pike GB; Collins DL
    Int J Comput Assist Radiol Surg; 2015 Jul; 10(7):1029-41. PubMed ID: 25249471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application value of multiparametric MRI for evaluating iron deposition in the substantia nigra in Parkinson's disease.
    Cao Q; Huang J; Tang D; Qian H; Yan K; Shi X; Li Y; Zhang J
    Front Neurol; 2022; 13():1096966. PubMed ID: 36686531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automatic detection of neuromelanin and iron in the midbrain nuclei using a magnetic resonance imaging-based brain template.
    Jin Z; Wang Y; Jokar M; Li Y; Cheng Z; Liu Y; Tang R; Shi X; Zhang Y; Min J; Liu F; He N; Yan F; Haacke EM
    Hum Brain Mapp; 2022 Apr; 43(6):2011-2025. PubMed ID: 35072301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromelanin-sensitive magnetic resonance imaging features of the substantia nigra and locus coeruleus in de novo Parkinson's disease and its phenotypes.
    Wang J; Li Y; Huang Z; Wan W; Zhang Y; Wang C; Cheng X; Ye F; Liu K; Fei G; Zeng M; Jin L
    Eur J Neurol; 2018 Jul; 25(7):949-e73. PubMed ID: 29520900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson's disease.
    Biondetti E; Gaurav R; Yahia-Cherif L; Mangone G; Pyatigorskaya N; Valabrègue R; Ewenczyk C; Hutchison M; François C; Arnulf I; Corvol JC; Vidailhet M; Lehéricy S
    Brain; 2020 Sep; 143(9):2757-2770. PubMed ID: 32856056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anatomical Templates of the Midbrain Ventral Tegmental Area and Substantia Nigra for Asian Populations.
    Nakamura Y; Okada N; Kunimatsu A; Kasai K; Koike S
    Front Psychiatry; 2018; 9():383. PubMed ID: 30210369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease-related increase of T2*-weighted hypointensity in substantia nigra pars compacta.
    Langley J; Huddleston DE; Sedlacik J; Boelmans K; Hu XP
    Mov Disord; 2017 Mar; 32(3):441-449. PubMed ID: 28004859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative assessment of iron deposition in the midbrain using 3D-enhanced T2 star weighted angiography (ESWAN): a preliminary cross-sectional study of 20 Parkinson's disease patients.
    Wang C; Fan G; Xu K; Wang S
    Magn Reson Imaging; 2013 Sep; 31(7):1068-73. PubMed ID: 23746648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromelanin magnetic resonance imaging of substantia nigra and locus coeruleus in Parkinson's disease with freezing of gait.
    Wang S; Wu T; Cai Y; Yu Y; Chen X; Wang L
    Front Aging Neurosci; 2023; 15():1060935. PubMed ID: 36819729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson's disease using neuromelanin-sensitive MRI: Replication in two cohorts.
    Hwang KS; Langley J; Tripathi R; Hu XP; Huddleston DE
    PLoS One; 2023; 18(4):e0282684. PubMed ID: 37053195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosing Parkinson's disease by combining neuromelanin and iron imaging features using an automated midbrain template approach.
    Jokar M; Jin Z; Huang P; Wang Y; Zhang Y; Li Y; Cheng Z; Liu Y; Tang R; Shi X; Min J; Liu F; Chen S; He N; Haacke EM; Yan F
    Neuroimage; 2023 Feb; 266():119814. PubMed ID: 36528314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NigraNet: An automatic framework to assess nigral neuromelanin content in early Parkinson's disease using convolutional neural network.
    Gaurav R; Valabrègue R; Yahia-Chérif L; Mangone G; Narayanan S; Arnulf I; Vidailhet M; Corvol JC; Lehéricy S
    Neuroimage Clin; 2022; 36():103250. PubMed ID: 36451356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous imaging of locus coeruleus and substantia nigra with a quantitative neuromelanin MRI approach.
    Chen X; Huddleston DE; Langley J; Ahn S; Barnum CJ; Factor SA; Levey AI; Hu X
    Magn Reson Imaging; 2014 Dec; 32(10):1301-6. PubMed ID: 25086330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroimaging Correlates of Substantia Nigra Hyperechogenicity in Parkinson's Disease.
    Prasuhn J; Strautz R; Lemmer F; Dreischmeier S; Kasten M; Hanssen H; Heldmann M; Brüggemann N
    J Parkinsons Dis; 2022; 12(4):1191-1200. PubMed ID: 35180131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease.
    Schwarz ST; Rittman T; Gontu V; Morgan PS; Bajaj N; Auer DP
    Mov Disord; 2011 Aug; 26(9):1633-8. PubMed ID: 21491489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.
    Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL
    Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.